CYP1A1 and CYP1B1 genetic variations might change enzymes functional characteristics in PAHs metabolism and ultimately influence the risk of CRC, which is increasing in Kirkuk governorate (Al Dahhan and Al Lami, 2018). This evidence concerns the gene CYP1B1 and colorectal carcinoma.